Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rationale and efficacy of proteasome inhibitor combined with arsenic trioxide in the treatment of acute promyelocytic leukemia.
Ganesan S, Alex AA, Chendamarai E, Balasundaram N, Palani HK, David S, Kulkarni U, Aiyaz M, Mugasimangalam R, Korula A, Abraham A, Srivastava A, Padua RA, Chomienne C, George B, Balasubramanian P, Mathews V. Ganesan S, et al. Among authors: kulkarni u. Leukemia. 2016 Nov;30(11):2169-2178. doi: 10.1038/leu.2016.227. Epub 2016 Aug 18. Leukemia. 2016. PMID: 27560113 Free PMC article.
Post-Transplant Cyclophosphamide as Sole Graft-versus-Host Disease Prophylaxis Is Feasible in Patients Undergoing Peripheral Blood Stem Cell Transplantation for Severe Aplastic Anemia Using Matched Sibling Donors.
George B, Pn N, Devasia AJ, Kulkarni U, Korula A, Lakshmi KM, Abraham A, Srivastava A, Mathews V. George B, et al. Among authors: kulkarni u. Biol Blood Marrow Transplant. 2018 Mar;24(3):494-500. doi: 10.1016/j.bbmt.2017.10.034. Epub 2017 Oct 31. Biol Blood Marrow Transplant. 2018. PMID: 29100905 Free article. Clinical Trial.
Arsenic Trioxide Enhances the NK Cell Cytotoxicity Against Acute Promyelocytic Leukemia While Simultaneously Inhibiting Its Bio-Genesis.
Alex AA, Ganesan S, Palani HK, Balasundaram N, David S, Lakshmi KM, Kulkarni UP, Nisham PN, Korula A, Devasia AJ, Janet NB, Abraham A, Srivastava A, George B, Padua RA, Chomienne C, Balasubramanian P, Mathews V. Alex AA, et al. Front Immunol. 2018 Jun 14;9:1357. doi: 10.3389/fimmu.2018.01357. eCollection 2018. Front Immunol. 2018. PMID: 29963052 Free PMC article.
Use of Non-Cryopreserved Peripheral Blood Stem Cells Is Associated with Adequate Engraftment in Patients with Multiple Myeloma Undergoing an Autologous Transplant.
Kulkarni U, Devasia AJ, Korula A, Fouzia NA, Nisham PN, Samoon YJ, Lakshmi KM, Abraham A, Srivastava A, Mathews V, George B. Kulkarni U, et al. Biol Blood Marrow Transplant. 2018 Dec;24(12):e31-e35. doi: 10.1016/j.bbmt.2018.08.007. Epub 2018 Aug 22. Biol Blood Marrow Transplant. 2018. PMID: 30142418 Free article.
Outcomes Following Allogeneic Stem Cell Transplantation Using Non-sibling Family Donors.
Korula A, Devasia AJ, Fouzia NA, Nisham PN, Kulkarni U, Lakshmi KM, Abraham A, Srivastava A, Mathews V, George B. Korula A, et al. Among authors: kulkarni u. Indian J Hematol Blood Transfus. 2019 Jan;35(1):43-49. doi: 10.1007/s12288-018-0988-z. Epub 2018 Aug 13. Indian J Hematol Blood Transfus. 2019. PMID: 30828147 Free PMC article.
Pharmacokinetics and Efficacy of Generic Melphalan Is Comparable to Innovator Formulation in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.
Pai AA, Devasia AJ, Panetta JC, Mani S, Stallon Illangeswaran RS, Mohanan E, Balakrishnan B, Lakshmi KM, Kulkarni U, Aboobacker FN, Korula A, Abraham A, Srivastava A, Mathews V, George B, Balasubramanian P. Pai AA, et al. Among authors: kulkarni u. Clin Lymphoma Myeloma Leuk. 2020 Feb;20(2):130-135.e1. doi: 10.1016/j.clml.2019.08.013. Epub 2019 Oct 4. Clin Lymphoma Myeloma Leuk. 2020. PMID: 31791694 Free PMC article.
120 results